CDEK by Data4ThePeople

Sign in Sign up

← All organizations

ReNetX Bio

For profitWebsite ↗

Also known as: ReNetX Bio | ReNetX Bio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2019

Defunct as of Dec 12, 2024

Timeline

2010s

Jun 1, 2010
ReNetX Bio— Founded

2020s

Dec 12, 2024
ReNetX Bio— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

axer-204

Indications

Studied for

Recent trials (2)

NCT03989440Lead sponsorPhase 1/Phase 2Jun 30, 2019
NCT03989440Study directorPhase 1/Phase 2Jun 30, 2019

Details

Founded: New Haven, CT, US Jun 1, 2010
Last known activity: Jun 30, 2019